Vertex Pharmaceuticals (VRTX) EV to CFO (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted EV to CFO of 104.85 for Q2 2026, up 40.93% on a QoQ basis from 74.4 in Q1 2026, and up 4.45% year-over-year from 100.38 in Q2 2025.
Vertex Pharmaceuticals (VRTX) EV to CFO (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported EV to CFO for 18 years, with the latest figure at 104.85 in Q2 2026.
- On a quarterly basis, EV to CFO rose 4.45% year-over-year to 104.85 in Q2 2026; TTM through Jun 2026 was 27.49, a 1.86% decrease from a year earlier, with the FY2025 full-year figure at 29.89, up 115.12% from the prior year.
- EV to CFO was 104.85 for Q2 2026 at Vertex Pharmaceuticals, up from 74.4 in the prior quarter.
- The five-year high for EV to CFO was 399.13 in Q4 2023, with the low at 30.67 in Q2 2024.
- Average EV to CFO over 5 years is 103.47, with a median of 74.95 recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: EV to CFO soared 578.45% in 2023, then tumbled 143.78% in 2024.
- Over 5 years, EV to CFO stood at 58.83 in 2022, then jumped by 578.45% to 399.13 in 2023, then sank by 58.28% to 166.53 in 2024, then jumped by 30.88% to 217.95 in 2025, then plunged by 51.9% to 104.85 in 2026.
- The last three EV to CFO figures came in at 104.85 (Q2 2026), 74.4 (Q1 2026), and 217.95 (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104.85 |
| Mar 31, 2026 | 74.40 |
| Dec 31, 2025 | 217.95 |
| Sep 30, 2025 | 75.05 |
| Jun 30, 2025 | 100.38 |
| Mar 31, 2025 | 144.56 |
| Dec 31, 2024 | 166.53 |
| Sep 30, 2024 | 82.75 |
| Jun 30, 2024 | -30.67 |
| Mar 31, 2024 | 74.85 |
| Dec 31, 2023 | 399.13 |
| Sep 30, 2023 | 61.28 |
| Jun 30, 2023 | 70.07 |
| Mar 31, 2023 | 78.59 |
| Dec 31, 2022 | 58.83 |
| Sep 30, 2022 | 67.54 |
| Jun 30, 2022 | 55.18 |
| Mar 31, 2022 | 61.14 |
| Dec 31, 2021 | 48.60 |
| Sep 30, 2021 | 42.61 |
Vertex Pharmaceuticals EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VRTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();